A clinical trial from @thelancetoncol.bsky.social explores whether advanced PET imaging improves outcomes over standard MRI for guiding re-irradiation in recurrent glioblastoma. It aligns with our journal's focus on how imaging influence treatment & patient lives 🔓https://bit.ly/thelancet-lanonc-642

We are happy to be media partners with the European Association for Cancer Research (EACR) for the #EACR2026 Congress: Innovative Cancer Science in Budapest, Hungary; June 8–11, 2026 Submit your abstract by March 4, 2026: 2026.eacr.org

🔴Online now: Ultra-hypofractionated versus conventionally fractionated radiotherapy for localised #prostatecancer (HYPO-RT-PC): 10-year outcomes of an open-label, randomised, phase 3, non-inferiority trial thelancet.com/journals/lan...

On #WorldCancerDay, stay up to date with the latest oncology content published across The Lancet Group. Explore our Specialty Collection: spkl.io/63327AsDNU

🆕 Greater transparency for oncology clinical trials reporting Chief Editors of The Lancet’s specialty journals discuss enhanced scrutiny in the reporting of oncology clinical trials Read here: thelancet.com/journals/lan...

✏️February's Editorial - Cancer: another casualty of geopolitical unrest? We discuss the deprioritisation of health care during geopolitical instability www.thelancet.com/journals/lan...

🆕Our Feb issue is live! 📉Articles: #NSCLC, #glioblastoma, #prostatecancer, #oesophagealcancer, and #coloncancer 📰Reviews: International Multidisciplinary Consensus Group for Malignant Spinal Cord Compression AND ReCOG consensus on multiple courses of RT thelancet.com/issue/S1470-...

🆕 “In this Viewpoint, we argue that trusted, hyperlocal, and globally present CHWs are a largely overlooked workforce in tackling the climate crisis, despite already doing work in adapting to and mitigating climate change.” Read the full Viewpoint now ➡️ www.thelancet.com/journals/lan...

Join our webinar on Feb 4, Improving Outcomes for Children with Serious Illness through Applied Qualitative Research Hosted by @stjuderesearch.bsky.social in collaboration with @thelancetoncol.bsky.social@thelancethaem.bsky.social @eclinicalmed.bsky.social stjudeglobal.zoom.us/meeting/regi...

As part of The Lancet Group’s partnership with IARC WHO for the #IARC60 Cancer Research into Action Conference, 19-21 May, 2026, @eclinicalmed.bsky.social will be publishing a best of special issue of conference abstracts Submit your abstract by 19 Jan iarc2026conf.iarc.who.int/en/abstracts...

@thelancetoncol.bsky.social, @thelancetph.bsky.social, @eclinicalmed.bsky.social are excited to partner with IARC for: #IARC60 Cancer Research into Action Conference Lyon, France, 19-21 May Submit your abstract by 19 Jan: iarc2026conf.iarc.who.int/en/abstracts... For more: iarc2026conf.iarc.who.int

🔴Online: Aumolertinib as adjuvant therapy in resected EGFR-mutated #NSCLC (ARTS): a double-blind, multicentre, randomised, controlled, phase 3 trial 📉Article thelancet.com/journals/lan... ✏️Comment thelancet.com/journals/lan...

Proton versus photon radiotherapy for patients with oropharyngeal cancer in the USA: a multicentre, randomised, open-label, non-inferiority phase 3 trial spkl.io/63327AmhOT

🔴Online now: Cilta-cel in lenalidomide-refractory #multiplemyeloma (CARTITUDE-4): an updated analysis including OS from an open-label, multicentre, randomised, phase 3 trial thelancet.com/journals/lan...

🔴Online first: A new Comment from Clare Turnbull and colleagues on the PATHFINDER2 study of GRAIL's Galleri multicancer detection blood test thelancet.com/journals/lan...

✏️Our Jan 2026 Editorial: Cancer consequences of the HIV funding crisis "Beyond the already devastating impact on the global burden of HIV, the disruptions seen in 2025 could have consequences beyond HIV and AIDS alone..." www.thelancet.com/journals/lan...

🆕Our Jan 26 issue! 📈Articles: #endometrialcancer, #NSCLC, #glioma, #prostatecancer, #oesophagealcancer, #pancreaticcancer 📄Reviews: Framework for glioma surgery by PIONEER and RANO resect 🖱️https://www.thelancet.com/issue/S1470-2045(25)X0013-9 2026 cover artist: J Specht (IG@ ju.liaspecht)

🔴Online now: FET-PET-guided versus contrast-enhanced T1-weighted MRI-guided re-irradiation in patients with recurrent #glioblastoma (GLIAA/NOA-10 ARO2013-01): a multicentre, open-label, randomised trial www.thelancet.com/journals/lan...

The Call for Abstracts for the #IARC60 Cancer Research into Action Conference, in Lyon, France, 19-21 May, 2026 is open Deadline for abstract submission: 19 Jan 2026 iarc2026conf.iarc.who.int/en/abstracts... More info on the conference website: iarc2026conf.iarc.who.int

🎉We're excited to announce our partnership with #IARCWHO for the #IARC60 Cancer Research into Action Conference, in Lyon, France, 19-21 May, 2026!🎉 Accepting abstract until 19 Jan 2026 iarc2026conf.iarc.who.int/en/abstracts... More info on the conference website: iarc2026conf.iarc.who.int

@thelancetoncol.bsky.social's highlights from the San Antonio Breast Cancer Symposium 2025, #SABCS25 Including trials ELEVATE, ASCENT-07, EPIK-B5, and DETECT V thelancet.com/journals/lan...

✏️This month's Editorial: Making prostate cancer screening fit for purpose www.thelancet.com/journals/lan...

🚨Our Dec issue is live! - thelancet.com/issue/S1470-... 📊Articles: #lungcancer, #breastcancer, #hepatocellularcarcinoma, #rectalcancer, #glioma 📑Reviews including neurocognitive outcomes in patients with brain metastases AND SISAQOL-IMI consensus guidelines on PROs in trials

🔴Online: Artificial intelligence and radiologists in #pancreaticcancer detection using standard of care CT scans (PANORAMA): an international, paired, non-inferiority, confirmatory, observational study thelancet.com/journals/lan...

Check out London Global Cancer Week #LGCW2025, running Nov 24 to Nov 28. www.lgcw.org.uk/lgcw-2025/ It's a pleasure for @thelancetoncol.bsky.social to sponsor another year!

News 🗞️Government shutdown and Medicare changes impact cancer care in the USA, reported by Sharmila Devi www.thelancet.com/journals/lan... 🗞️More e-cigarette users than cigarette smokers for the first time in the UK, reported by Manjulika Das www.thelancet.com/journals/lan...

📊Online now: Effectiveness of NELSON versus PLCOm2012 #lungcancer screening eligibility criteria in Germany (HANSE): a prospective cohort study thelancet.com/journals/lan... ✏️Comment: Defining eligibility for lung cancer screening based on individual risk thelancet.com/journals/lan...

🚨 A new @thelancetoncol.bsky.social Commission warns of a growing “human crisis” in cancer. Despite scientific advances, many patients are not getting the compassionate, holistic support they need. Authors call for a shift towards more human-centered care: tinyurl.com/5x3rmnsv

🚨Our Nov issue is live - thelancet.com/issue/S1470-... 📊Articles: #breastcancer, #NSCLC, #prostatecancer, #melanoma 📰 Reviews: Tumour-infiltrating lymphocyte therapy in the era of genetic engineering AND AI for Response Assessment in Pediatric Neuro-Oncology (AI-RAPNO)

🆕Online: Overall survival assessment in cancer drug trials: a luxury or a necessity? Samuel X Stevens, @lateuwen.bsky.social, and Bishal Gyawali discuss the #FDA draft guidance on overall survival in randomised cancer drug trials thelancet.com/journals/lan...

🚨Our Oct issue is live - thelancet.com/issue/S1470-... 📈Articles: on #RCC, #SCLC, #NSCLC, #BladderCancer, #Myeloma, #PancreaticCancer, #EndometrialCancer, and #ThyroidCancer 📝Reviews: EU–CAYAS–NET recommendations for health-care transitions in young people beyond childhood cancer

No time to wait: resilience as a cornerstone for primary health care across Latin America and the Caribbean, a World Bank-PAHO Lancet Regional Health Americas Commission - The Lancet Regional Health – Americas www.thelancet.com/journals/lan...

Oncolytic viruses have the unique ability to selectively replicate within (and to destroy) cancer cells, offering a promising approach in cancer treatment. A new Review summarises clinical progress, remaining challenges, & future research directions: tinyurl.com/9667u3ab

Cancer deaths expected to rise to over 18 million in 2050—an increase of nearly 75% from 2024, study forecasts. Explore the data ▶️ tinyurl.com/5n7dfnws @ihmeuw.bsky.social #NCDs

🚨Our Sept issue is live - 25 years! thelancet.com/journals/lan... 📊Articles #renalcellcarcinoma, #prostatecancer, #meningioma, #thymiccarcinoma, & #colorectalcancer Reviews: 📰 ESTRO and ASTRO plus endorsed guidelines on vol delineation & 📰 Common Sense Oncology and EORTC on reporting QoL data

Our inaugural issue is out now! 🎉 Explore and download our first issue and read featured content, Editor's picks, announcements, and much more on our journal homepage: hubs.li/Q03GFPRK0 Thank you to our authors and reviewers! #medsky #physician-researcher #obgynsky #womenshealthsky

We have also launched our podcast channel, which is available in several places: Buzzsprout: thelancetobgynwomenshealth.buzzsprout.com Apple: podcasts.apple.com/us/podcast/t... Spotify: open.spotify.com/show/66s00Mx... We launch with two podcasts: check them out now!

@thelancetoncol.bsky.social is pleased to announce we are partnering with @estroradiotherapy.bsky.social and Radiotherapy and Oncology for a second year at next year’s Congress in Stockholm. Please submit your abstracts! www.estro.org/Congresses/E...

Super session announcing a new @thelancet.com @iaslc.bsky.social Commission on lung cancer at this year’s WCLC 2025 in Barcelona

New at The Lancet Public Health - Targeting alcohol use in high-risk population groups: a US microsimulation study of beverage-specific pricing policies www.thelancet.com/journals/lan... #alcohol #LiverSky #MedSky

“The world cannot afford another crisis in which lives are lost not for lack of vaccines, but for lack of truth.” A new Comment on the global cost of US vaccine misinformation: bit.ly/3Uu7b5o

🔴Online today: Health-related quality of life in patients with KRASG12C-mutated chemorefractory metastatic #colorectalcancer treated with sotorasib plus panitumumab or standard of care (CodeBreaK 300): results from a phase 3, randomised clinical trial thelancet.com/journals/lan...

🗞️News: Kenya adopts digitally enabled cancer-care model, Paul Adepoju reports “This is just the beginning...What we're building is not just software. It's a system that puts people at the centre.” Lucy Mithu (Roche East Africa) told The Lancet Oncology www.thelancet.com/journals/lan...

Our September 2025 issue is out now at www.thelancet.com/gastrohep! Content includes viral hepatitis, irritable bowel syndrome, diet, colorectal surgery, Crohn's disease, MASLD, primary biliary cholangitis, and more... #GastroSky #MedSky #HepSky #IBDSky

Stay ahead in your field! 📣 Connect directly to late-breaking content published by The Lancet Group presented at global conferences and related events in your field, right from your inbox. Find out more: hubs.li/Q03BhlSK0

Regulation of #endocrine #tumours by aberrant #GPCR is not restricted to cortisol-secreting adrenal lesions, but also occurs in tumours of several other organs www.thelancet.com/journals/lan... #MedSky #EndoSky #OncSky

📢Can't wait till our next issue? Stay connected with The Lancet Primary Care’s Update Alerts! Receive curated content, exclusive features, and more delivered straight to your inbox in between issues. Sign up today! hubs.li/Q03BhmQt0 #medsky #familymedicinesky #internalmedicinesky

Just published in The Lancet Oncology, updated ESGO–ESTRO–ESP guidelines on the treatment of endometrial carcinoma www.thelancet.com/journals/lan... @thelancetoncol.bsky.social

🚨Online today: Prognostic and predictive value of baseline PSMA-PET total tumour volume and SUVmean in metastatic castration-resistant #prostatecancer in #ENZAp (ANZUP1901): a substudy from a multicentre, open-label, randomised, phase 2 trial www.thelancet.com/journals/lan...

🚨Clinical picture quiz: An 89-year-old patient was referred urgently following a 10-day headache. The patient recalled that colon cancer had been diagnosed 2 weeks earlier, and a basal cell carcinoma of the head 3 years earlier